D
Silo Pharma, Inc. SILO
$0.64 $0.06912.08% NASDAQ
Recommendation
Prev Close
$0.64
Volume
64,091
Avg Vol (90D)
596,125
Market Cap
$4.61M
Dividend & Yield
--
52-Week Range
$0.4101 - $4.50
P/E (TTM)
--
EPS (TTM)
-$1.19
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
6/5/2025 - GuruFocus
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset SILO ...
6/5/2025 - GuruFocus
Silo Pharma (SILO) Allocates $1 Million for Bitcoin Investment SILO Stock News
6/5/2025 - GuruFocus
Silo Pharma board approves purchase of bitcoin as treasury reserve
6/5/2025 - The Fly
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
6/5/2025 - Globe Newswire
Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Up 181.7% in May
5/29/2025 - Ticker Report
Silo Pharma's (NASDAQ:SILO) Groundbreaking Therapies Could Change The Treatment Landscape For PTSD, Fibromyalgia, MS & Alzheimer's
5/27/2025 - Simply Wall St
Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug
5/21/2025 - SeekingAlpha.com: All News
Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug
5/21/2025 - Seeking Alpha - Healthcare
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug ...
5/21/2025 - GuruFocus
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
5/21/2025 - GuruFocus
Silo Pharma, Resyca partner for intranasal drug-device study of SPC-15
5/21/2025 - The Fly
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
5/21/2025 - Globe Newswire
Silo Pharma Completes Public Offering, Raises $1.56 Million
5/16/2025 - TipRanks Financial Blog
Silo Pharma Announces Closing of $2 Million Public Offering
5/16/2025 - GuruFocus
Silo Pharma Announces Closing of $2 Million Public Offering SILO Stock News
5/16/2025 - GuruFocus
Silo Pharma Announces Closing of $2 Million Public Offering
5/16/2025 - Globe Newswire
Silo Pharma Announces Pricing of $2 Million Public Offering SILO Stock News
5/15/2025 - GuruFocus
Silo Pharma Announces Pricing of $2 Million Public Offering
5/15/2025 - GuruFocus
Silo Pharma announces pricing of $2 million public offering
5/15/2025 - Seeking Alpha - Healthcare
Silo Pharma prices 3.3M shares at 60c in public offering
5/15/2025 - TipRanks Financial Blog
Silo Pharma prices 3.3M shares at 60c in public offering
5/15/2025 - The Fly
Silo Pharma Announces Pricing of $2 Million Public Offering
5/15/2025 - Globe Newswire
Silo Pharma Retail Buzz Surges On FDA Toxicology Study Plans For PTSD Treatment
5/15/2025 - Stocktwits News Feed
Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel ...
5/14/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$72.00K
EBITDA (TTM)
-$2.82M
EBIT (TTM)
-$4.71M
Net Income (TTM)
-$4.39M
Balance Sheet
Total Assets (Q)
$7.41M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$2.38M
Book Value Per Share (Q)
$1.12
Cash Flow
Cash from Operations (TTM)
-$3.83M
Cash from Investing (TTM)
$973.80K
Cash from Financing (TTM)
$3.24M
Net Change in Cash (TTM)
$381.50K
Filings
Filing Date
Friday, March 28, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
0.99
7-Day Total Return
39.43%
30-Day Total Return
-43.86%
60-Day Total Return
-50.77%
90-Day Total Return
-64.05%
Year to Date Total Return
-32.63%
1-Year Total Return
-45.76%
2-Year Total Return
-71.43%
3-Year Total Return
-91.17%
5-Year Total Return
-97.16%
52-week Low
May 22, 2025 - $0.4101
52-week High
Jul 18, 2024 - $4.50
Valuation
Market Cap
$4.61M - Nano Cap
Enterprise Value
-$838.44K
Price/Sales (TTM)
40.00
Price/Book (Q)
0.57
Dividends and Shares
Shares Outstanding
4.49M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
silopharma.com
Phone Number
718 400 9031
Address
677 North Washington Boulevard
Sarasota, FL 34236
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder... more
NASDAQ 06/05/2025 4:00PM Eastern Quotes delayed